The rapid growth in the number of patients with psychological disorders puts immense pressure on the economy, society, and healthcare systems. Various classes of drugs have been approved for different psychological disorders; however, a vast number of these medicines experience first-pass metabolism and low bioavailability, plasma level fluctuations, side effects, and the need for frequent daily doses, which all lead to poor patient compliance. Besides, the mental condition of these patients…
